V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70098171 | 70063468 | 1.05 | 51 | Curative (C) | 2019-02-15 | 2019-02-22 | ALL UKALL2011 TRIAL | 01 | 0 | ALL UKALL2011 TRIAL | 101837654 |
| 80007656 | 80035308 | 0 | 20.1 | null | 2018-08-11 | 2018-10-20 | CYCLOPHOSPHAMIDE | 01 | 0 | CISPLATIN + DOXORUBICIN + METHOTREXATE + VINBLASTINE | 100597634 |
| 70104157 | 70066124 | 1.68 | 89.6 | Curative (C) | 2019-03-27 | 2019-04-02 | null | null | 0 | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE + GO | 100744091 |
| 70065633 | 70096138 | 1.7 | 107.8 | Curative (C) | 2016-10-18 | 2016-11-10 | CHOP R | N | 0 | CHOP R | 101509511 |
| 70074511 | 70099824 | 1.77 | 82 | Curative (C) | 2019-01-11 | 2019-02-04 | Brentuximab | N | 0 | BRENTUXIMAB | 100410184 |
| 70074624 | 70099897 | null | null | Curative (C) | 2017-06-18 | 2017-11-19 | ALL Relapse Blinatumomab | 02 | 0 | NOT MATCHED | 101678364 |
| 70075098 | 70100142 | 1.62 | 89 | Curative (C) | 2018-05-07 | 2018-05-13 | ALL Interfant 06 MARMA: Ph I | 02 | 0 | CISPLATIN + GEMCITABINE + RITUXIMAB | 100920589 |
| 70097201 | 70114463 | 1.8 | 76.9 | Curative (C) | 2018-05-21 | 2018-12-17 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE | null | 0 | CARBOPLATIN + FLUOROURACIL | 101063080 |
| 70055185 | 70114713 | 1.88 | 85.5 | Palliative (P) | 2018-05-12 | 2018-05-12 | BENDAMUSTINE + BORTEZOMIB | N | 0 | ALL RELAPSE: CYCLOPHOSPHAMIDE + CYTARABINE + NAVITOCLAX + VENETOCLAX | 100657201 |
| 150012840 | 150007037 | null | 3.5 | Adjuvant (A) | 2017-05-05 | 2017-05-11 | Temozolomide + RT | 02 | 0 | TEMOZOLOMIDE + RT | 101174273 |
| 150015925 | 150008615 | 1.62 | 83 | Curative (C) | 2017-07-20 | 2017-07-20 | null | 01 | 0 | TEMOZOLOMIDE + RT | 100801722 |
| 80055927 | 80043577 | 1.67 | 55 | null | 2017-03-16 | 2018-10-11 | FLUOROURACIL + OXALIPLATIN | 01 | 0 | TRIAL | 101014289 |
| 80050596 | 80047700 | null | 13.3 | null | 2015-10-31 | 2015-10-31 | WT SIOP 2002 01 post op Vinc alone | 01 | 0 | FLUOROURACIL + IRINOTECAN | 100281714 |
| 70101109 | 70064899 | 1.7 | 68 | Curative (C) | null | 2019-06-18 | null | null | 0 | UKALL60+ | 101375330 |
| 70099607 | 70141026 | 1.6 | 101 | null | 2018-09-28 | 2018-12-22 | null | null | 0 | BEACOPP | 101123755 |
| 70099791 | 70141079 | 1.75 | 53 | null | 2017-11-19 | 2017-11-21 | null | 99 | 0 | ALEMTUZUMAB | 100292976 |
| 70079073 | 70143536 | 1.8 | 26.1 | Curative (C) | 2019-08-13 | 2019-10-19 | Gemcitabine + Capecitabine | 99 | 0 | ALL INT GUIDE B INT MAINT | 100747802 |
| 70065803 | 70130733 | 1.74 | 68.4 | 03 | 2019-07-04 | 2020-02-08 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | 0 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100405095 |
| 80069027 | 80052557 | 1.63 | 10.1 | Curative (C) | 2019-11-30 | 2020-01-27 | null | 01 | 0 | DOCETAXEL | 101787310 |
| 80063144 | 80051409 | 0 | 101.4 | Curative (C) | 2017-10-02 | 2017-10-03 | Carboplatin + Etoposide iv&po | 01 | 0 | NIRAPARIB | 101727590 |
| 70068261 | 70154393 | 1.63 | 81 | Curative (C) | 2019-07-10 | 2020-01-08 | CHOP R - 21 days | 02 | 0 | CHOP R | 100838484 |
| 70075618 | 70156089 | 1.56 | 115 | 03 | 2017-04-21 | 2018-04-09 | Brentuximab | N | 0 | BRENTUXIMAB | 101099583 |
| 70079498 | 70163117 | 0 | 21 | Curative (C) | 2019-06-16 | 2019-06-16 | Ipilimumab | 2 | 0 | IGEV R | 101052931 |
| 70071141 | 70170406 | 1.6 | null | Curative (C) | 2017-05-06 | 2017-05-06 | CHOP R - 21 days | N | 0 | CHOP R | 101316441 |
| 70074592 | 70188325 | 1.82 | 64.3 | Disease modification (D) | null | 2022-04-09 | CHOP R - 21 days | N | 0 | CHOP R | 101220109 |
| 70098782 | 70140730 | 1.82 | 49.8 | null | null | 2016-05-02 | null | 01 | 0 | AZACITIDINE + VENETOCLAX | 100875275 |
| 70089155 | 70056964 | 1.59 | 64 | null | 2018-06-29 | 2018-06-30 | FLAIR trial | 01 | 1 | FLAIR TRIAL | 100539296 |
| 90042624 | 90045329 | 1.58 | 80.9 | Curative (C) | 2016-10-23 | 2017-05-03 | Carboplatin AUC 6 - 10 | 02 | 2 | CARBOPLATIN | 101400896 |
| 70031047 | 70177831 | 1.66 | 57 | Neo-adjuvant (N) | 2020-07-22 | 2020-08-01 | Rituximab | 02 | 2 | RITUXIMAB | 100564408 |
| 70029239 | 70147698 | 1.76 | 61 | 03 | 2018-08-20 | 2019-02-11 | Rituximab (SUBCUTANEOUS Maintenance) | N | 2 | RITUXIMAB | 100278482 |
| 70060296 | 70153166 | 1.7 | 63 | Not known (9) | null | 2018-08-16 | Bortezomib +/- Dexamethasone | 2 | 2 | BORTEZOMIB | 101382529 |
| 70028665 | 70147553 | 1.51 | 74.7 | Curative (C) | 2018-09-06 | 2018-09-06 | Rituximab (Maintenance) | 02 | 2 | RITUXIMAB | 101590650 |
| 90031119 | 90013883 | 1.62 | 140 | null | null | 2019-02-08 | CARBOPLATIN + PACLITAXEL | null | 2 | CARBOPLATIN + PACLITAXEL | 101131989 |
| 90032649 | 90014597 | 1.68 | 78.6 | Adjuvant (A) | 2016-08-24 | 2016-10-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 100821339 |
| 90033636 | 90015097 | 1.61 | 68 | null | 2017-08-22 | 2017-09-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101353802 |
| 90034210 | 90015373 | 1.48 | 72.8 | Neo-adjuvant (N) | 2020-01-17 | 2020-01-18 | CARBOPLATIN + PACLITAXEL | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101499765 |
| 90034510 | 90015508 | 1.59 | 72 | null | 2016-05-24 | 2016-05-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 100161308 |
| 90035364 | 90015927 | 1.63 | 49 | null | 2017-03-14 | 2017-03-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 100305473 |
| 90027582 | 90012260 | 1.58 | 54.2 | Adjuvant (A) | 2018-05-07 | 2018-05-16 | CARBOPLATIN + PACLITAXEL | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101066120 |
| 90041979 | 90019047 | 1.75 | 65.6 | Curative (C) | 2017-09-25 | 2017-09-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101396699 |
| 90043014 | 90019532 | 1.51 | 73.6 | Palliative (P) | 2017-02-16 | 2017-02-18 | CARBOPLATIN + PACLITAXEL | N | 2 | CARBOPLATIN + PACLITAXEL | 101683095 |
| 90043880 | 90019935 | 1.61 | 65 | null | 2017-04-08 | 2017-04-22 | CARBOPLATIN + PACLITAXEL | 02 | 2 | CARBOPLATIN + PACLITAXEL | 100374154 |
| 90044477 | 90020229 | 1.49 | 119 | Adjuvant (A) | 2018-06-07 | 2018-06-27 | CARBOPLATIN + PACLITAXEL | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101736259 |
| 90046225 | 90021077 | 1.47 | 55.4 | null | 2017-07-29 | 2017-08-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 100907398 |
| 90051069 | 90023371 | 1.58 | 81.5 | Palliative (P) | 2020-01-12 | 2020-01-12 | Carboplatin AUC 6 - 10 | 02 | 2 | CARBOPLATIN | 101664021 |
| 90064498 | 90029451 | 1.7 | 73.5 | Curative (C) | 2017-04-05 | 2017-04-14 | Doxorubicin + Olaratumab | 02 | 2 | CISPLATIN + RT | 101848248 |
| 90064526 | 90029470 | 154 | 56 | Palliative (P) | 2016-05-19 | 2016-06-09 | BEP 5 Day | 02 | 2 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101776457 |
| 90014495 | 90031939 | 1.64 | 75.6 | Curative (C) | 2019-12-15 | 2019-12-16 | CARBOPLATIN + ETOPOSIDE | 2 | 2 | PACLITAXEL | 101776674 |
| 90042602 | 90045316 | 1.65 | 64.3 | Adjuvant (A) | 2017-01-11 | 2017-06-13 | Carboplatin AUC 6 - 10 | N | 2 | CARBOPLATIN | 100731708 |
| 90040467 | 90018289 | 1.61 | 52.6 | Curative (C) | 2022-01-10 | 2022-01-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101094211 |